tiprankstipranks
Trending News
More News >
Ispire Technology, Inc. (ISPR)
:ISPR
US Market
Advertisement

Ispire Technology, Inc. (ISPR) AI Stock Analysis

Compare
40 Followers

Top Page

IS

Ispire Technology, Inc.

(NASDAQ:ISPR)

Rating:54Neutral
Price Target:
$2.50
▼(-11.66%Downside)
Ispire Technology's stock score is primarily influenced by financial challenges, including profitability and cash flow issues. Strategic initiatives and the Malaysian license offer growth potential, but current financial pressures limit the stock's attractiveness.

Ispire Technology, Inc. (ISPR) vs. SPDR S&P 500 ETF (SPY)

Ispire Technology, Inc. Business Overview & Revenue Model

Company DescriptionIspire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited
How the Company Makes MoneyIspire Technology, Inc. generates revenue through the sale of its electronic devices and accessories. The company leverages a retail and wholesale distribution model, selling its products directly to consumers through its online platform and partnering with retailers and distributors to reach a broader market. Additionally, Ispire Technology may engage in licensing agreements for its proprietary technologies, providing an additional revenue stream. Strategic partnerships with key industry players allow the company to expand its market reach and product offerings, contributing to its overall earnings.

Ispire Technology, Inc. Earnings Call Summary

Earnings Call Date:May 12, 2025
(Q3-2025)
|
% Change Since: -6.60%|
Next Earnings Date:Sep 23, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture. While there are significant advancements in strategic initiatives such as manufacturing expansion in Malaysia and innovative product developments, the company faced notable financial challenges, including a decline in revenue, increased operating expenses, and a higher net loss. The strategic efforts may position the company for future growth, but current financial pressures indicate areas of concern.
Q3-2025 Updates
Positive Updates
Reduction in Accounts Receivable
Accounts receivable decreased by approximately $7.3 million from the previous quarter to $60.4 million, demonstrating improved payment and collection policies.
Malaysian Manufacturing Expansion
Secured interim nicotine product manufacturing license in Malaysia, with plans to expand to 80 production lines, enhancing manufacturing capacity and reducing geopolitical risk.
Innovative Age-Gating Technology
Filed a PMTA for a blockchain-based age-gating system with the FDA, promising enhanced public health and regulatory compliance.
Partnership with Raw Garden
Launched the Sprout cannabis vapor device in partnership with Raw Garden, emphasizing purity, performance, and safety.
Negative Updates
Revenue Decline
Total revenue decreased by 12.7% to $26.2 million compared to $30 million in the same period last year, impacted by tariffs and manufacturing transitions.
Decreased Gross Margins
Gross margins for Q3 dropped to 18.2% from 20.4% last year.
Increased Operating Expenses
Operating expenses increased to $15.4 million from $11.8 million last year, due to higher stock-based compensation, bad debt expense, and restructuring costs.
Net Loss
Net loss for the third fiscal quarter increased to $10.9 million, or $0.19 per share, compared to $5.9 million, or $0.11 per share, last year.
Company Guidance
During the Ispire Technology Third Quarter 2025 Earnings Call, several key metrics and strategic developments were highlighted. The company reported a revenue of approximately $26.2 million for the third quarter, a decrease from $30 million in the same period of fiscal 2024, reflecting a 12.7% drop. Accounts receivable were reduced by $7.3 million to $60.4 million, indicating improved financial management. The gross profit for the quarter was $4.8 million, down from $6.1 million in the prior year, with gross margins decreasing to 18.2% from 20.4%. On a nine-month basis, gross profit increased to $20.2 million, with an improved gross margin of 18.8%. Operational expenses rose to $15.4 million, leading to a net loss of $10.9 million, or $0.19 per share. The company has secured an interim nicotine product manufacturing license in Malaysia and anticipates a final manufacturer's license soon, with plans to expand to 80 production lines. Additionally, Ispire highlighted its joint venture, IKE Tech LLC, which filed a component PMTA for a blockchain-based age-gating system with the FDA. This innovation aims to enhance safety and compliance in the electronic nicotine delivery systems market.

Ispire Technology, Inc. Financial Statement Overview

Summary
Ispire Technology, Inc. faces significant profitability challenges, with negative net profit and EBITDA margins despite positive revenue growth. The balance sheet is stable but burdened by high liabilities, and cash flow generation remains volatile.
Income Statement
45
Neutral
Ispire Technology, Inc.'s income statement shows challenges with profitability. The gross profit margin remains positive, but the company faces a negative net profit margin, indicating significant losses. Revenue growth has been positive from 2021 to 2023, but recent figures suggest instability in achieving sustainable profitability. The EBIT and EBITDA margins are also negative, highlighting operational inefficiencies.
Balance Sheet
60
Neutral
The balance sheet reflects a relatively stable equity ratio, but the company has a high level of total liabilities compared to its stockholders' equity, resulting in a moderate debt-to-equity ratio. The return on equity is negative due to net losses, indicating inefficiency in generating returns for shareholders. Nevertheless, the company maintains a strong cash position, which provides some resilience.
Cash Flow
50
Neutral
The cash flow statement indicates volatility in cash flow generation. Operating cash flow has been negative, but the company has managed to keep free cash flow slightly positive in the TTM period. The operating and free cash flow to net income ratios are concerning, suggesting challenges in converting earnings to cash effectively.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue151.91M115.61M88.10M63.41M
Gross Profit29.78M21.08M13.31M10.42M
EBITDA-11.76M-3.68M-843.13K3.65M
Net Income-14.77M-6.10M-1.87M2.94M
Balance Sheet
Total Assets122.64M90.69M100.74M93.86M
Cash, Cash Equivalents and Short-Term Investments35.07M49.43M74.48M85.25M
Total Debt3.40M4.30M347.54K478.11K
Total Liabilities88.18M59.32M88.97M80.11M
Stockholders Equity34.46M31.37M11.77M13.76M
Cash Flow
Free Cash Flow-21.45M-8.60M-7.68M5.02M
Operating Cash Flow-18.30M-7.58M-7.56M5.02M
Investing Cash Flow2.99M-10.15M-121.52K-798.00
Financing Cash Flow10.08M-16.44M-3.09M-227.85K

Ispire Technology, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.83
Price Trends
50DMA
2.69
Positive
100DMA
3.06
Negative
200DMA
4.34
Negative
Market Momentum
MACD
0.08
Negative
RSI
56.18
Neutral
STOCH
59.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ISPR, the sentiment is Positive. The current price of 2.83 is above the 20-day moving average (MA) of 2.66, above the 50-day MA of 2.69, and below the 200-day MA of 4.34, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 56.18 is Neutral, neither overbought nor oversold. The STOCH value of 59.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ISPR.

Ispire Technology, Inc. Risk Analysis

Ispire Technology, Inc. disclosed 47 risk factors in its most recent earnings report. Ispire Technology, Inc. reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ispire Technology, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
TPTPB
75
Outperform
$1.40B34.3427.53%0.38%3.17%-2.23%
RLRLX
73
Outperform
$2.88B32.554.07%0.34%75.72%-6.45%
63
Neutral
$34.16B5.47-11.67%1.85%5.30%-18.30%
54
Neutral
$161.72M-110.47%-1.69%-106.13%
44
Neutral
$2.38M-385.90%-56.65%99.11%
38
Underperform
$4.31M-113.32%-78.81%92.54%
31
Underperform
$5.94M-88.92%-71.85%59.22%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ISPR
Ispire Technology, Inc.
2.92
-4.10
-58.40%
XXII
22nd Century
4.90
-2,651.12
-99.82%
TPB
Turning Point Brands
78.82
42.36
116.18%
GNLN
Greenlane Holdings
3.46
-2,356.04
-99.85%
KAVL
Kaival Brands Innovations Group
0.52
-0.71
-57.72%
RLX
RLX Technology
2.33
0.56
31.64%

Ispire Technology, Inc. Corporate Events

Executive/Board ChangesShareholder Meetings
Ispire Technology Holds Annual Stockholders Meeting
Neutral
Jun 26, 2025

Ispire Technology Inc. held its Annual Meeting of Stockholders on June 24, 2025, where 49,588,338 shares were represented. During the meeting, stockholders elected five directors for a one-year term and ratified the appointment of Marcum Asia LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2025.

The most recent analyst rating on (ISPR) stock is a Buy with a $12.50 price target. To see the full list of analyst forecasts on Ispire Technology, Inc. stock, see the ISPR Stock Forecast page.

Product-Related AnnouncementsBusiness Operations and StrategyRegulatory Filings and Compliance
Ispire Technology Secures Malaysian License for Nicotine Products
Positive
May 23, 2025

On May 22, 2025, Ispire Technology Inc. announced it received an interim license from the Malaysian Government for manufacturing nicotine products, marking it as the only company with full authorization for export, import, and production in Malaysia. This approval allows Ispire to immediately begin manufacturing and marketing its nicotine products in Malaysia, significantly expanding its production capabilities and strategically positioning itself as a leading international provider of vaping hardware.

The most recent analyst rating on (ISPR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Ispire Technology, Inc. stock, see the ISPR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 09, 2025